CSW
CSW Industrials, Inc.
CSW has a slight edge over RKLB overall, supported by lower modeled downside.
RKLB
Rocket Lab USA, Inc.
RKLB offers stronger fundamentals, but that advantage does not outweigh its weaker overall profile.
CSW Fundamentals
| Metric | Status |
|---|---|
| Strong | |
| Healthy | |
| Strong | |
| Under pressure |
CSW's revenue, profitability and cash flow are currently healthy, but its balance sheet is under pressure.
RKLB Fundamentals
| Metric | Status |
|---|---|
| Strong | |
| Under pressure | |
| Weak | |
| Unavailable |
RKLB's revenue is currently strong, but its profitability and cash flow are under pressure. There isn't enough data to rate its balance sheet.
CSW PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Forward | 22x | $282 | — |
| Cheap | 25x | $198 | -30% |
| Fair | 34x | $263 | -6.7% |
| Current | 36x | $282 | — |
| Expensive | 43x | $333 | +18% |
Historical ranges are pointers, not guarantees.
CSW's PE is in its fair range at 36x. If earnings grow as analysts expect, today's price would be 22x next year's earnings, in its cheap range.
RKLB PE Valuation
RKLB has no meaningful PE right now: it lost money over the past year.
CSW Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Growth | |
| Growth | |
| Improving | |
| Limited | |
| Moderate |
Analysts expect earnings and revenue growth for CSW, with profitability improving.
RKLB Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses shrinking | |
| Strong growth | |
| Strongly improving | |
| Limited | |
| Low |
Analysts expect RKLB's losses to shrink, with revenue growing. However, they disagree widely on these estimates.
CSW Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $13.06 | +67% |
| Q3 2026 | $7.80 | -8.1% |
| Q2 2026 | $7.31 | -12% |
| Q1 2026 | $6.70 | -20% |
| Q4 2025 | $7.51 | -10% |
| Q3 2025 | $8.49 | +16% |
| Q2 2025 | $8.34 | +19% |
| Q1 2025 | $8.38 | +29% |
| Q4 2024 | $8.36 | +34% |
CSW has the edge over RKLB on earnings quality, reporting a profit while its opponent remains loss making.
RKLB Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | -$0.36 | +$0.03 |
| Q2 2026 | -$0.27 | +$0.19 |
| Q1 2026 | -$0.32 | +$0.09 |
| Q4 2025 | -$0.37 | +$0.01 |
| Q3 2025 | -$0.39 | -$0.02 |
| Q2 2025 | -$0.46 | -$0.11 |
| Q1 2025 | -$0.41 | -$0.04 |
| Q4 2024 | -$0.38 | $0.00 |
RKLB is still losing money, but less than at its worst: $0.36 per share over the past year, against $0.46 at its worst in mid-2025.
CSW Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $361.4M | +31% |
| Q2 2026 | $350.7M | +33% |
| Q1 2026 | $309M | +34% |
| Q4 2025 | $233M | +20% |
| Q3 2025 | $277M | +22% |
| Q2 2025 | $263.6M | +17% |
| Q1 2025 | $230.5M | +9.3% |
| Q4 2024 | $193.6M | +11% |
CSW's revenue has grown year over year every quarter since late 2020: $361M last quarter, up 31% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 21% | +0.4 points |
| Q2 2026 | 23% | +2 points |
| Q1 2026 | 13% | -6.7 points |
| Q4 2025 | 7.4% | -7.8 points |
| Q3 2025 | 21% | -2.1 points |
| Q2 2025 | 21% | -3.5 points |
| Q1 2025 | 20% | -1.5 points |
| Q4 2024 | 15% | -0.5 points |
CSW has the edge over RKLB on profitability, with a higher operating margin.
RKLB Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $267.8M | +73% |
| Q2 2026 | $234.1M | +62% |
| Q1 2026 | $200.3M | +63% |
| Q4 2025 | $179.7M | +36% |
| Q3 2025 | $155.1M | +48% |
| Q2 2025 | $144.5M | +36% |
| Q1 2025 | $122.6M | +32% |
| Q4 2024 | $132.4M | +121% |
RKLB has the edge over CSW on sales, with stronger typical year-over-year growth.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -30% | +8.5 points |
| Q2 2026 | -25% | +17 points |
| Q1 2026 | -28% | +20 points |
| Q4 2025 | -28% | +11 points |
| Q3 2025 | -38% | +12 points |
| Q2 2025 | -41% | -0.5 points |
| Q1 2025 | -48% | -1.9 points |
| Q4 2024 | -39% | +41 points |
RKLB's operating margin was −30% last quarter, up 8.5 points from the same quarter a year ago.
CSW Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $91.9M | +56% |
| Q2 2026 | $69.6M | +21% |
| Q1 2026 | -$6.8M | -130% |
| Q4 2025 | $22.7M | +169% |
| Q3 2025 | $58.7M | -4.2% |
| Q2 2025 | $57.7M | -3.1% |
| Q1 2025 | $22.8M | +30% |
| Q4 2024 | $8.5M | -80% |
CSW has the edge over RKLB on cash generation, producing positive trailing cash flow while its opponent burns cash.
RKLB Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$23.9M | +$45.5M |
| Q2 2026 | -$110.1M | -$54.8M |
| Q1 2026 | -$77.4M | +$5.5M |
| Q4 2025 | -$114.2M | -$90.2M |
| Q3 2025 | -$69.4M | -$27.5M |
| Q2 2025 | -$55.3M | -$26.9M |
| Q1 2025 | -$82.9M | -$61.1M |
| Q4 2024 | -$23.9M | +$28.7M |
RKLB has burned cash in almost every quarter: −$326M over the past year, against −$232M the year before.
CSW Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.2% | -32K shares |
| 1 year | -3% | -509K shares |
| 3 years | +4.8% | +745K shares |
| 5 years | +3.3% | +522K shares |
| Available history | +7.1% | +1.1M shares |
CSW has the edge over RKLB on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $5.8M |
| Q2 2026 | $36.3M |
| Q1 2026 | $34M |
| Q4 2025 | $72.7M |
| Q3 2025 | $17M |
| Q2 2025 | $9.1M |
| Q1 2025 | $6.8M |
| Q4 2024 | $8.6M |
CSW spent $149M buying back its own shares over the past year, about four times what it spent the year before.
RKLB Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +3.6% | +22.6M shares |
| 1 year | +23% | +124M shares |
| 3 years | +35% | +168M shares |
| 5 years | +46% | +204M shares |
RKLB has 652M diluted shares, up 23% from a year ago.
| Quarter | Spent |
|---|---|
| Q4 2020 | — |
| Q2 2020 | — |
| Q1 2020 | — |
CSW Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 2.5x | Moderate |
| Q2 2026 | 3.1x | Elevated |
| Q1 2026 | 3.6x | Elevated |
| Q4 2025 | 3.3x | Elevated |
| Q3 2025 | 0.1x | Very low |
| Q2 2025 | 0.3x | Very low |
| Q1 2025 | -1.0x | Net Cash |
| Q4 2024 | -1.0x | Net Cash |
CSW's net debt is about 2.5 years of its operating earnings (EBITDA), up from less than a year a year ago.
RKLB Net Leverage
RKLB's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.
CSW Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 46.0 | Neutral |
| Stochastic | 10.8 | Oversold |
CSW's weekly RSI is 46 (neutral) and its Stochastic is 11 (oversold).
RKLB Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 46.8 | Neutral |
| Stochastic | 27.6 | Neutral |
RKLB's weekly RSI is 47 (neutral) and its Stochastic is 28 (neutral).
CSW PE vs Industrials Sector
| Metric | CSW | Sector median | Relative |
|---|---|---|---|
| PE | 36x | 24x | 50% above |
| PE % | 57 | 58 | 1 pt below |
CSW is trading at 36x earnings, a 50% premium to the Industrials sector's median of 24x.
RKLB PE vs Industrials Sector
RKLB has no meaningful PE right now: it lost money over the past year.
CSW Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $288.8 | 2.5% below |
| 20 week MA | $299.8 | 6.1% below |
| 50 week MA | $292.5 | 3.8% below |
| 100 week MA | $292.2 | 3.7% below |
| 200 week MA | $259.4 | 8.5% above |
CSW has fallen below most of its moving averages, though it's still 8.5% above its 200-week average.
RKLB Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $61.4 | 4.3% above |
| 20 week MA | $68.1 | 5.9% below |
| 50 week MA | $77.6 | 17% below |
| 100 week MA | $56.5 | 13% above |
| 200 week MA | $31.4 | 104% above |
RKLB has the edge over CSW on trend strength, trading above more of its moving averages.
CSW Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $77.3 | $111.7 | +45% |
| 2021 | $111.7 | $117.0 | +4.8% |
| 2022 | $117.0 | $117.2 | +0.1% |
| 2023 | $117.2 | $207.4 | +77% |
| 2024 | $207.4 | $357.4 | +72% |
| 2025 | $357.4 | $307.3 | -14% |
| 2026 YTD | $307.3 | $281.6 | -8.4% |
CSW has the edge over RKLB on returns for 2026, with the stronger performance.
RKLB Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $9.82 | $10.3 | +4.9% |
| 2021 | $10.3 | $12.0 | +17% |
| 2022 | $12.0 | $3.77 | -69% |
| 2023 | $3.77 | $5.53 | +47% |
| 2024 | $5.53 | $27.2 | +392% |
| 2025 | $27.2 | $70.7 | +160% |
| 2026 YTD | $70.7 | $64.1 | -9.3% |
RKLB's yearly returns have swung widely, from +392% in 2024 to −69% in 2022. It's down 9.3% so far in 2026.